Need Help? Call 1­-866-­796-­7386
« back to stock screener

  VRX stock: Valeant Pharmaceuticals Intl I

Current Rating
Strong Buy

Previous Rating

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$19.71
Market Cap
5.85B
Sector
Health Care
Div. Growth
-
P/E
4.4
P/B
1.13
P/S
0.67
Dividend %
-
P/CF
4.6
P/FCF
2.9
Op. Cash Flow
2.22M
FCF
5.9
Op. Margin
5.70%
Net Margin
15.40%
ROE
33.80%
ROI
-1.60%
ROA
3.30%
EPS Growth
160.60%
Current Ratio
1.4
Debt/Equity
946.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Apollo Medical Holdings Inc (AMEH) $18.16 - - 58.5M Strong Buy
Teva Pharmaceutical Industries (TEVA) $18.61 - 5.60% 14.96B Strong Buy
NovaBay Pharmaceuticals, Inc. (NBY) $3.35 - - 64.5M Strong Buy
Nature's Sunshine Prod. (NATR) $12.10 - 3.20% 242.9M Strong Buy
CV Sciences Inc (CVSI) $0.36 - - 21.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More